13G Filing: Scopia Capital Raises Stake in Insys Therapeutics, Inc. (INSY)

Page 11 of 12

Page 11 of 12 SEC Filing

Exhibit A
AGREEMENT
The
undersigned agree that this Schedule 13G dated March 10, 2016 relating to the Common Stock, $0.01 par value of Insys
Therapeutics, Inc. shall be filed on behalf of the undersigned.
SCOPIA CAPITAL MANAGEMENT LP
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  COO
SCOPIA MANAGEMENT, INC.
By: /s/ Aaron Morse
Name:  Aaron Morse
Title:  Vice President
By: /s/ Matthew Sirovich
Name:  Matthew Sirovich
By: /s/ Jeremy Mindich
Name:  Jeremy Mindich

Follow Insys Therapeutics Inc. (NASDAQ:INSY)

Page 11 of 12